These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22385710)

  • 21. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
    Kelly P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
    [No Abstract]   [Full Text] [Related]  

  • 22. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer: in regard to Diez P, et al. (Int J Radiat Oncol Biol Phys 2010;77:1066-1071).
    Williams SG
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):639; author reply 639-40. PubMed ID: 21549251
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Rickles DJ
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
    [No Abstract]   [Full Text] [Related]  

  • 24. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 25. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions: in regard to Morikawa and Roach III (Int J Radiat Oncol Biol Phys 2011 May 1;80:6-16).
    Revannasiddaiah S; Gupta MK; Seam RK; Madabhavi I
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1318; author reply 1318. PubMed ID: 22385711
    [No Abstract]   [Full Text] [Related]  

  • 26. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
    Williams S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
    [No Abstract]   [Full Text] [Related]  

  • 27. In regard to Lee et al.: "Dosimetry and cancer control after low-dose-rate prostate brachytherapy" (Int J Radiat Oncol Biol Phys 2005;61:52-59).
    Shanahan TG; Mueller PW; Maxey RB
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):311-2; author reply 312. PubMed ID: 16111606
    [No Abstract]   [Full Text] [Related]  

  • 28. Response to "the impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy" (Int J Radiat Oncol Biol Phys 2011;79:379-384).
    Oymak E; Onal C
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1603; author reply 1603-4. PubMed ID: 21740997
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience: in regard to BLOCH et al. (Int J Radiat Oncol Biol Phys 2007;69:70-78).
    Beaulieu L; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1289; author reply 1289-90. PubMed ID: 18572093
    [No Abstract]   [Full Text] [Related]  

  • 30. In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
    Lee WR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):319; author reply 319-20. PubMed ID: 15093929
    [No Abstract]   [Full Text] [Related]  

  • 31. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Hyde C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 33. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer: in regard to Arcangeli C, et al. (Int J Radiat Oncol Biol Phys 2010;78:11-18).
    Vogelius IR; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):316; author reply 316-7. PubMed ID: 21481731
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Froehner M; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?: in regard to King CR (Int J Radiat Oncol Biol Phys 2011;80:1-3).
    Catton CN; Parker CC; Sydes MR
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1594. PubMed ID: 22115563
    [No Abstract]   [Full Text] [Related]  

  • 36. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. In regard to Bhojani et al. (Int J Radiat Oncol Biol Phys 2010;76:342-348.).
    Weber DC; Combescure C
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):314-5; author reply 315. PubMed ID: 20708488
    [No Abstract]   [Full Text] [Related]  

  • 37. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 38. What approach will lead to cure of glioblastoma multiforme? In regard to Barani et al. (Int J Radiat Oncol Biol Phys 2007;68:324-333) and Jones and Sanghera (Int J Radiat Oncol Biol Phys 2007;68:441-448).
    Nieder C
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):640-1; author reply 641. PubMed ID: 17869682
    [No Abstract]   [Full Text] [Related]  

  • 39. 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery.
    Milickovic N; Mavroidis P; Tselis N; Nikolova I; Katsilieri Z; Kefala V; Zamboglou N; Baltas D
    Med Phys; 2011 Sep; 38(9):4982-93. PubMed ID: 21978042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In regard to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401): Incorporating clinical measurements of hypoxia into tumor control modeling of prostate cancer: implications for the alpha/beta ratio.
    Orton CG
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1637; author reply 1637-9. PubMed ID: 15050348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.